Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



Isansys: Sepsis can be detected early using new technology enabling patients to receive timely treatment

Research by BBC News this week showed that a quarter of patients with sepsis have experienced delays in getting treatment. Hospitals are supposed to put a person on an antibiotic drip within an hour if sepsis is suspected but research by BBC News suggests a quarter of patients in England wait longer

Read the rest of entry »

University of Birmingham Enterprise welcomes progress in new treatment for Idiopathic Intracranial Hypertension (IIH)

5 July 2019: University of Birmingham Enterprise welcomes the floatation of Invex Therapeutics, which is developing an innovative new treatment approach for IIH discovered at the University of Birmingham, UK.

Read the rest of entry »

Utility Team: Up and coming energy experts, and OBN Exclusive Energy Partner,  Utility Team win prestigious award on their way to the top

Coventry based company Utility Team have clearly established their place in the energy arena. Standing out from the crowd and establishing that customer service is palpably of upmost importance and a high priority to them by winning the prestigious TELCA Award- Best Customer Service for Large Customers.

Read the rest of entry »

Results Healthcare: The healthcare industry: primed to profit from AI and machine learning

Artificial Intelligence (AI) and machine learning in life sciences and healthcare holds the promise of reforming the industry. Generating and harnessing mass pools of data, the healthcare and life science industries are particularly primed to profit from the potential of AI, offering the unearthing of hidden insights in a world of unstructured data.

Read the rest of entry »

CHAIN Biotechnology: Cancer vaccine firm Oxford Vacmedix announces collaboration and Innovate UK grant

Oxford Vacmedix UK Limited (OVM), the UK-based biopharma company focused on the development of cancer vaccines, announced today the award of an Innovate UK grant to CHAIN Biotechnology Ltd (CHAIN) and the University of Oxford to develop live biotherapeutics that support oral delivery for OVM’s recombinant overlapping peptide (ROP) cancer vaccines.

Read the rest of entry »

Emergex Signs an R&D Agreement with IMCB to Develop a Vaccine for the Emerging Threat of Hand, Foot & Mouth Disease

Emergex Vaccines Holding Limited (‘Emergex’), a biotechnology company pioneering a new approach to synthetic vaccine development in the field of infectious diseases, today announced that it has signed an R&D agreement with the Institute of Molecular and Cell Biology (IMCB) in Singapore to develop a fully synthetic vaccine against human viruses that cause Hand, Foot and Mouth Disease (HFMD).

Read the rest of entry »

Medherant positions itself for the next stage of its development with the appointment of a new CEO

Coventry, UK, 25th June 2019 / Medherant Limited (“Medherant”), the clinical-stage company developing innovative products for pain and CNS diseases using a unique transdermal delivery technology, TEPI Patch®, has appointed John Burt as Chief Executive Officer, effective 24 June 2019

Read the rest of entry »

University of Birmingham in €4m project to train researchers to improve sight-saving treatments

24 June 2019: Treatment of diseases of the back of the eye such as age-related macular degeneration (AMD) and diabetic eye disease is set to be improved with a €4m EU-funded project led by Waterford Institute of Technology (WIT) in partnership with the University of Birmingham.

Read the rest of entry »

ScreenIn3D, a partner of AMSBIO, Wins Technology Innovation Prize

ScreenIn3D, a partner of AMSBIO, has received a share of the £1 million plus prize pot and will receive ongoing support from partners of Scottish Edge - a respected regional business support agency.

Read the rest of entry »

Twist Bioscience Launches Mouse Exome to Power Genetic Research

SAN FRANCISCO--(BUSINESS WIRE)--Jun. 17, 2019-- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the launch of the Twist Mouse Core Exome Panel, the most comprehensive, up-to-date tool for interrogation of the mouse exome, further enabling genetic research of this important model organism.

Read the rest of entry »

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.